Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1993 Nov 20;307(6915):1318–1322. doi: 10.1136/bmj.307.6915.1318

Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women.

I Stensvold 1, A Tverdal 1, P Urdal 1, S Graff-Iversen 1
PMCID: PMC1679451  PMID: 8257886

Abstract

OBJECTIVE--To study the association between non-fasting serum triglyceride concentrations and mortality in women from coronary and cardiovascular disease and all causes. DESIGN--Follow up by ambulatory teams of men and women who underwent cardiovascular screening for a mean of 14.6 years. SETTING--National health screening service in Norway. SUBJECTS--25,058 men and 24,535 women aged 35-49 years. MAIN OUTCOME MEASURE--Predictive value of non-fasting serum triglyceride concentrations. RESULTS--At initial screening total serum cholesterol concentration, serum triglyceride concentration, blood pressure, height, and weight were measured, and self reported information about smoking habits, physical activity, and time since last meal were recorded. During subsequent follow up 108 women died from coronary heart disease, 238 from cardiovascular diseases, and 931 from all causes. In women mortality increased steadily with increasing triglyceride concentration for all three causes of death. With the proportional hazards model and adjustment for age, systolic blood pressure, total cholesterol concentration, time since last meal, and number of cigarettes a day the relative risk between triglyceride concentration > or = 3.5 mmol/l and < 1.5 mmol/l was 4.7 (95% confidence interval 2.5 to 8.9) for deaths from coronary heart disease, 3.0 (1.9 to 4.8) for deaths from cardiovascular disease, 2.3 (1.8 to 2.9) for total deaths in all women. CONCLUSIONS--A raised non-fasting concentration of triglycerides is an independent risk factor for mortality from coronary heart disease, cardiovascular disease, and any cause mortality among middle aged Norwegian women in contrast to what is seen in men.

Full text

PDF
1318

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austin M. A., Krauss R. M. Genetic control of low-density-lipoprotein subclasses. Lancet. 1986 Sep 13;2(8507):592–595. doi: 10.1016/s0140-6736(86)92425-6. [DOI] [PubMed] [Google Scholar]
  2. Austin M. A. Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. Am J Epidemiol. 1989 Feb;129(2):249–259. doi: 10.1093/oxfordjournals.aje.a115130. [DOI] [PubMed] [Google Scholar]
  3. Bjartveit K., Foss O. P., Gjervig T., Lund-Larsen P. G. The cardiovascular disease study in Norwegian counties. Background and organization. Acta Med Scand Suppl. 1979;634:1–70. [PubMed] [Google Scholar]
  4. Carlson L. A., Böttiger L. E. Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. Acta Med Scand. 1985;218(2):207–211. doi: 10.1111/j.0954-6820.1985.tb08848.x. [DOI] [PubMed] [Google Scholar]
  5. Costongs G. M., Janson P. C., Bas B. M., Hermans J., van Wersch J. W., Brombacher P. J. Short-term and long-term intra-individual variations and critical differences of clinical chemical laboratory parameters. J Clin Chem Clin Biochem. 1985 Jan;23(1):7–16. [PubMed] [Google Scholar]
  6. Folsom A. R., Wu K. K., Davis C. E., Conlan M. G., Sorlie P. D., Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis. 1991 Dec;91(3):191–205. doi: 10.1016/0021-9150(91)90167-2. [DOI] [PubMed] [Google Scholar]
  7. Fontbonne A. Insulin. A sex hormone for cardiovascular risk? Circulation. 1991 Sep;84(3):1442–1444. doi: 10.1161/01.cir.84.3.1442. [DOI] [PubMed] [Google Scholar]
  8. Hulley S. B., Rosenman R. H., Bawol R. D., Brand R. J. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med. 1980 Jun 19;302(25):1383–1389. doi: 10.1056/NEJM198006193022503. [DOI] [PubMed] [Google Scholar]
  9. Lapidus L., Bengtsson C., Lindquist O., Sigurdsson J. A., Rybo E. Triglycerides--main lipid risk factor for cardiovascular disease in women? Acta Med Scand. 1985;217(5):481–489. doi: 10.1111/j.0954-6820.1985.tb03251.x. [DOI] [PubMed] [Google Scholar]
  10. Natvig H., Borchgrevink C. F., Dedichen J., Owren P. A., Schiotz E. H., Westlund K. A controlled trial of the effect of linolenic acid on incidence of coronary heart disease. The Norwegian vegetable oil experiment of 1965-66. Scand J Clin Lab Invest Suppl. 1968;105:1–20. [PubMed] [Google Scholar]
  11. Reaven G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595–1607. doi: 10.2337/diab.37.12.1595. [DOI] [PubMed] [Google Scholar]
  12. Stensvold I., Urdal P., Thürmer H., Tverdal A., Lund-Larsen P. G., Foss O. P. High-density lipoprotein cholesterol and coronary, cardiovascular and all cause mortality among middle-aged Norwegian men and women. Eur Heart J. 1992 Sep;13(9):1155–1163. doi: 10.1093/oxfordjournals.eurheartj.a060331. [DOI] [PubMed] [Google Scholar]
  13. Tverdal A., Foss O. P., Leren P., Holme I., Lund-Larsen P. G., Bjartveit K. Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men. Am J Epidemiol. 1989 Mar;129(3):458–465. doi: 10.1093/oxfordjournals.aje.a115157. [DOI] [PubMed] [Google Scholar]
  14. Westlund K., Nicolaysen R. Ten-year mortality and morbidity related to serum cholesterol. A follow-up of 3.751 men aged 40-49. Scand J Clin Lab Invest Suppl. 1972;127:1–24. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES